OPTH Optimi Health Corp.
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them…
Industry Peers
Drug Manufacturers - Specialty & Generic| Headline | Source | Time |
|---|---|---|
Older | ||
Optimi Health Completes Psilocybin Production for Phase 2 MDD Trial Optimi Health (OPTI.CN) said Wednesday it completed a production batch of 5-mg naturally derived psi | ||
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Key Takeaways; Psychedelic Sector Optimi Health Plans to Initiate Phase 3 Clinical Trial Evaluating MDMA Therapy for Individuals with PTSD Eli Lilly Completed $2.8 Billion Acquisition of AtaiBeckley, Expanding its Mental Health Pipeline Definium’s Phase 3 Panorama Trial Delivered Positive Results for DT120 in Generalized Anxiety Disorder Psyence BioMed Established Texas Entity to Advance U.S. […] | ||
 Elon Musk Once Said Psychedelics Could Help PTSD — Now FDA Holds Hearing as Optimi Health Advances MDMA Trial Shares of Optimi Health Corp. and other commercial manufacturers of MDMA and psilocybin are in focus, following federal administrative actions, a public hearing on psychedelic medicines, and an old endorsement of these drugs by tech billionaire Elon Musk. Optimi Health... | ||
 These Biotech Stocks Are Cheap Based On 1 Fundamental Measure Biotech stocks can offer high reward opportunities. Here are three North American biotech stocks that could offer both growth and value. | ||
 3 Small Cap Stocks With Strong Revenue Growth And Low Debt Rising rates are squeezing indebted businesses. Meet three small cap stocks with strong revenue growth and low debt, plus a screener to find more like them. | ||
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Key Takeaways; Cannabis Sector Aurora Cannabis Urged Shareholders to Reject Curaleaf’s Hostile Takeover Bid Tilray Expanded Global Cannabis Production as International Medical Demand Continues to Grow Key Takeaways; Psychedelic Sector Jupiter Neurosciences Raised $2 Million as the Company Advances its Parkinson’s Drug Program Optimi Health Secured Discretionary Equity Facility as Psychedelic Drug Business Expands SciSparc […] | ||
 3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Now Psychedelics stocks are becoming more popular as more research goes into them. Here are 3 stock ideas for your watchlist. | ||
 Optimi Health Establishes $100 Million Equity Facility as Psychedelic Commercialisation Advances Optimi Health has added financial flexibility to its growth strategy as it advances its MDMA and psilocybin business. | ||
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Key Takeaways; Cannabis Sector Curaleaf Holdings Announced Intention to Launch a Hostile Takeover Bid to Acquire Aurora Cannabis Organigram Posted Record Quarter as Sanity Group Acquisition Fueled Global Expansion Key Takeaways; Psychedelic Sector Optimi Health Set Up US$100 Million Equity Facility to Support Growth Definium Therapeutics’ Phase 3 Trial Delivered Strong Results for DT120 in […] | ||
 3 Psychedelic Stocks With Potential Clinical Trial Catalysts Big pharma is funding a field it once dismissed. These three psychedelic stocks carry possible clinical catalysts as the healthcare industry turns to alternative medicines. | ||